Diabetes Flashcards
Microvascular complications
Retinopathy, Nephropathy , peripheral neuropathy, autonomic neuropathy (erectile dysfunction, gastroparesis, loss of bladder control, UTIs)
Rest factors for type two diabetes
- First degree relative with diabetes
- Race:Native American, African-American, Asian American, Hispanic, Pacific Islander
- Overweight with a BMI >/=25 kg/m²
- Physical inactivity
- Hypertension or taking hypertension medication
- HDL less than 35 and/or triglycerides >250
- History of cardiovascular disease
- A1C >/= 5.7%
- Women who delivered a baby weighing more than 9 pounds or who had gestational diabetes
- Women with polycystic ovary syndrome
- Other conditions associated with insulin resistance examples are severe obesity, acanthosis nigricans
Macrovascular complications
Coronary artery disease, cerebrovascular disease, peripheral artery disease
Diagnostic criteria for diabetes
- Classics symptoms such as polyuria, polydipsia, and unexplained weight loss
- Fasting plasma glucose >/= 126
- Two hour plasma glucose of greater than 200
- A1C >= 6.5%
Goals of treatment
A1C < 140/80 mmHg (ACE/ARB 1st line)
Cholesterol: LDL less than 100 (all diabetics with an LDL of 70 or higher and who are age 40–75 should be taking a moderate or high-intensity statin)
Lifestyle modifications
- Weight loss: shoot for a 7% decrease and a waist circumference less than 35 inches for females and less than 40 inches for men
- Diet: low-carb, low fat
- Exercise: at least 150 minutes per week
- All patients who smoke should receive cessation counseling
Comprehensive Care
- Primary prevention of CV disease: 81 mg aspirin if major risk factors such as family history of CVD, HTN, smoking, dyslipidemia, or albuminuria
- Nephropathy screening: annual urine test for albumin (looking for micro albumin 30-299 mg/day) ACE/ARB should be used for HTN to protect kidneys
- Retinopathy screening: annual dilated comprehensive eye exam is recommended in patients with diabetes
- Foot care: annual foot exam performed by a podiatrist and daily by patient
Vaccinations for adults with diabetes
- HepB if 19-59yo and never completed series
- Influenza: annually
- PPSV23 (pneumovax): at 2-64 yo and again at >65 if >5 years since previous vaccination
- TdaP: once afterward Td every 10 years
ADA treatment algorithm for type two diabetes
- Lifestyle modification
- Metformin monotherapy unless contraindicated
- If A1C not at goal within 3 months consider adding a second agent (sulfonylurea, TZD, DPP-4, GLP-1, insulin)
- still not at goal w/in 3 months: add 3rd agent
Biguanide
Metformin (glucophage)
PREGNANCY CATEGORY B
MOA: decrease hepatic glucose production; can also decrease intestinal absorption of glucose and improve insulin sensitivity
A1C: 1-2% decrease
Blackbox warning: lactic acidosis (more risk when used with alcohol or in the case of renal/ hepatic impairment)
Symptoms of lactic acidosis: weakness, sleepiness, decreased HR, cold, muscle pain, SOB, stomach pain, lightheaded
Contraindications: Scr >= 1.5 men or 1.4 women; CrCl < 60, metabolic acidosis, DC if patient receiving iodinated contrast media do not start until 48 hours after procedure
Warning: should be stopped in any case of hypoxia such as decompensated heart failure, respiratory failure, acute MI or sepsis; avoid in anyone with hepatic impairment
Side effects: diarrhea, nausea, vomiting, flatulence, weight neutral, Little to no risk of hypoglycemia
Metformin combo drugs
\+ Glipizide (Metaglip) \+ glyburide (Glucovance) \+ Poglitazone (Actosplus met) \+ rosiglitazone (avandamet) \+ sitagliptan (JANUMET) \+ saxagliptan (kombiglyze XR) \+ linagliptan (jentadueto) \+ alogliptan (kazano)
Sulfonylurea
Chlorpropamide (diabinese): 1st gen agent
Glipizide (glucotrol)
Glimeperide (amaryl)
Glyburide (diabeta): only one that is renally adj.
MOA: stimulate insulin secretion from the pancreatic beta cells
Warning: sulfa allergy, do not use with Meglitinides (prandin and starlix) due to similar MOA
SIDE EFFECTS: HYPOGLYCEMIA (most associated with chlorpropamide and glyburide) and weight gain
Drug interactions: do not use with insulin due to hypoglycemic
Counseling: keep away from children, do not take or not eating, recognize the signs and symptoms of low blood sugar
Meglitinides
Repaglinide (prandin)
Nateglinide (starlix)
MOA: stimulate excellent secretion from the pancreatic beta cells; do not use with sulfonylureas due to similar MOA
Dosing: take approximately 30 minutes before meals as used for postprandial glucose
Side effects: hypoglycemia, mild weight gain, upper respiratory tract infection
Drug interactions: gemfibrozil increases Prandin concentrations and can decrease blood glucose recommend Fenofibrate instead
Counseling: take 30 minutes prior to meals if you forget to take those before eating skip that does take it your next meal; do not take if not eating, keep away from children
TZD
Pioglitazone (actos)
Risoglitazone (avandia)
MOA: PPARy agonists that increase peripheral insulin sensitivity (insulin sensitizers)
Blackbox warning: make exacerbate or cause heart failure in some patients; do not initiate therapy in patients with NYHA class 3/4 heart failure
Warning: do not use Poglitazone in patients with active bladder cancer
Side effects: peripheral edema, weight gain, URTIs, CHF, increase fracture risk, increased LFTs, Poglitazone has increased risk of bladder cancer beyond one year, (increase HDL, decrease triglycerides and total cholesterol for Actos)
Counseling: may take several weeks for the drug to lower blood sugar, take once daily with or without food, contact your doctor right away if you’re passing dark colored urine, have pale stools, feel more tired than usual with your skin and/or whites of your eyes become yellow, this drug can cause water retention
Alpha glucosidase inhibitors
Acarbose (precose)
Miglitol (glyset)
Pregnancy category B
MOA: inhibit alpha glucosidases resulting in delayed glucose absorption and lowering of postprandial hyperglycemia (also causes increased satiety)
Dosing: take with the first bite of each meal (needs to be in the stomach with your food); do not use If CrCL less than 25
Contraindications: IBD, colonic ulceration, partial or complete intestinal obstruction
Side effects: G.I. effects (flatulence, diarrhea, abdominal pain), weight neutral
Counseling: this drug does not cause hypoglycemia but if hypoglycemia is present you cannot treat with sucrose, things present in fruit juices, or with table sugar/candy, you must purchase glucose tablets of gel to have on hand to treat any hypoglycemic episode as sucrose will not be absorbed normally